glp-1 sarcopenia Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of and Sarcopenic Obesity | Current Nutrition Reports Lean mass loss on GLP-1

While some patients achieve stable outcomes with minimal contact, others require more intensive and ongoing psychotherapy, underscoring the need for a steppedcare approach tailored to psychosocial vulnerabilities and evolving needs [146]

References "Assessment of the Efficacy of Cryolipolysis on Abdominal Fat Deposits: A Prospective Study," Aesthetic Plastic Surgery , May 3, 2023

consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs

The fastest wins usually come from three unglamorous levers: hydrate early (with electrolytes when appropriate), set a repeatable protein anchor, and keep intake steady with smaller regular meals rather than long gaps

Its extended activity allows for longer biological exposure compared to natural IGF-1, which has led to interest in research and clinical settings